Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mathea

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Biochemical Journal|January 18, 2021
Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanismsAsad U Malik, Athanasios Karapetsas, Raja S Nirujogi, et al.
European Journal of Medicinal Chemistry|August 29, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1Theresa E Mensing, Christian G Kurz, Jennifer A Amrhein, et al.
The Journal of Biological Chemistry|June 14, 2024
A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2Verena Dederer, Marta Sanz Murillo, Eva P Karasmanis, et al.
Science Advances|June 7, 2024
Mechanism of human PINK1 activation at the TOM complex in a reconstituted systemOlawale G Raimi, Hina Ojha, Kenneth Ehses, et al.
Frontiers in Cell and Developmental Biology|June 20, 2022
A Toolbox for the Generation of Chemical Probes for Baculovirus IAP Repeat Containing ProteinsMartin P Schwalm, Lena M Berger, Maximilian N Meuter, et al.
European Journal of Medicinal Chemistry|April 26, 2024
Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterizationAnthony Champiré, Rayan Berabez, Abdennour Braka, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
The structural basis for LRRK2's activation and autoinhibitionAmalia Villagran Suarez, Kathryn S Hatch, Tatyana Bodrug, et al.
ACS Chemical Biology|April 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 InhibitorSebastian Mandel, Thomas Hanke, Sebastian Mathea, et al.
Biochemistry|November 29, 2018
Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1"Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Biochemistry|March 21, 2018
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|January 18, 2021
Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanismsAsad U Malik, Athanasios Karapetsas, Raja S Nirujogi, et al.
European Journal of Medicinal Chemistry|August 29, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1Theresa E Mensing, Christian G Kurz, Jennifer A Amrhein, et al.
The Journal of Biological Chemistry|June 14, 2024
A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2Verena Dederer, Marta Sanz Murillo, Eva P Karasmanis, et al.
Science Advances|June 7, 2024
Mechanism of human PINK1 activation at the TOM complex in a reconstituted systemOlawale G Raimi, Hina Ojha, Kenneth Ehses, et al.
Frontiers in Cell and Developmental Biology|June 20, 2022
A Toolbox for the Generation of Chemical Probes for Baculovirus IAP Repeat Containing ProteinsMartin P Schwalm, Lena M Berger, Maximilian N Meuter, et al.
European Journal of Medicinal Chemistry|April 26, 2024
Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterizationAnthony Champiré, Rayan Berabez, Abdennour Braka, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
The structural basis for LRRK2's activation and autoinhibitionAmalia Villagran Suarez, Kathryn S Hatch, Tatyana Bodrug, et al.
ACS Chemical Biology|April 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 InhibitorSebastian Mandel, Thomas Hanke, Sebastian Mathea, et al.
Biochemistry|November 29, 2018
Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1"Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Biochemistry|March 21, 2018
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Pageof 6